Compugen Ltd (NAS:CGEN)
$ 1.54 0.04 (2.67%) Market Cap: 136.12 Mil Enterprise Value: 25.92 Mil PE Ratio: 50.78 PB Ratio: 2.27 GF Score: 53/100

Q1 2024 Compugen Ltd Earnings Call Transcript

May 20, 2024 / 12:30PM GMT
Release Date Price: $1.74 (-17.54%)
Operator

Ladies and gentlemen, thank you for joining us today and welcome to Compugen's First Quarter 2024 Results Conference Call. At this time, all participants are in a listen only mode and audio webcast of this call is available in the Investors section of Compugen's website, www.ccbn.com.

As a reminder, today's call is being recorded. I would now like to introduce Yvonne Naughton, Head of Investor Relations and Corporate Communications. Yvonne, please go ahead.

Yvonne Naughton
Compugen Ltd - Head of Investor Relations and Corporate Communications

Thank you, operator, and thank you all for joining us on the call today. Joining me from Compugen for the prepared remarks are Dr. Anat Cohen-Dayag, President and Chief Executive Officer, and Alberto SSR, Chief Financial Officer, Dr. Michelle Miller, Chief Medical Officer, and Dr. Ron affair, Chief Scientific Officer, will join us for the Q&A.

Before we begin, we would like to remind you that during this call, the Company may make

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot